Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2017-10-12Clinical Trial Update: Measure of Engagement of Epilepsy Patients in Messaging Groups [NA]
Clinical trial assessing engagement of epilepsy patients in messaging groups; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2017-10-09Clinical Trial Update: Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy [Phase 4]
This Phase 4 clinical trial update reports on measuring serum levels of two antiepileptic drugs during conversion in patients with epilepsy,…
-
CLINICAL_TRIALS trial_result · 2017-10-06Clinical Trial Update: Clinical and Immunological Investigations of Subtypes of Autism
This clinical trial studied immunological subtypes of autism and has completed. The study involved participants with autism spectrum disorde…
-
CLINICAL_TRIALS trial_result · 2017-10-06Clinical Trial Update: Connectivity Analysis for Investigation of Auditory Impairment in Epilepsy
A terminated clinical trial sponsored by NIDCD examined connectivity analyses related to auditory impairment in epilepsy. The study status i…
-
FDA label_change · 2017-10-05FDA Approved: DEPAKOTE SPRINKLES — Supplemental Application (AbbVie Inc.)
FDA approved a labeling supplement for Depakote Sprinkles (divalproex sodium) submitted by AbbVie.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2017-10-05FDA Approved: DEPAKOTE — Supplemental Application (AbbVie Inc.)
FDA approved AbbVie's supplemental application for Depakote (divalproex sodium), leading to changes to the product labeling.
-
FDA approval · 2017-09-28FDA Approved: LEVETIRACETAM — Original Application (Hisun Pharmaceuticals USA, Inc.)
FDA approved Hisun Pharmaceuticals USA, Inc.'s original application for a generic levetiracetam product.
-
EMA guidance · 2017-09-26EMA's first public hearing: giving EU citizens a voice to help reduce the risk of valproate
EMA held its first public hearing to involve EU citizens in reducing the risk associated with valproate use, aiming to give patients a voice…
-
CLINICAL_TRIALS trial_result · 2017-09-26Clinical Trial Update: An Open Label Study to Evaluate the Effects of Ezogabine/Retigabine Added to Existing Anti-epileptic Drug(s) on Urinary Voiding Function in Subjects With Partial Onset Seizures [Phase 4]
Open-label Phase 4 trial evaluating ezogabine/retigabine added to existing anti-epileptic drugs on urinary voiding function in adults with p…
-
FDA approval · 2017-09-14FDA Approved: BRIVIACT — Supplemental Application (UCB, Inc.)
FDA approved a supplemental application for Briviact (brivaracetam) submitted by UCB, Inc.
-
FDA approval · 2017-09-14FDA Approved: BRIVIACT — Supplemental Application (UCB, Inc.)
FDA approved a supplemental application for Briviact (brivaracetam) from UCB, authorizing changes to its labeling.
-
CLINICAL_TRIALS trial_result · 2017-09-14Clinical Trial Update: Cognitive and Behavioral Effects of Lacosamide [Phase 4]
Phase 4 clinical trial update evaluating cognitive and behavioral effects of lacosamide in epilepsy is completed.
-
FDA approval · 2017-09-13FDA Approved: APTIOM — Supplemental Application (Sumitomo Pharma America, Inc.)
The FDA approved a supplemental application for APTIOM (eslicarbazepine acetate) submitted by Sumitomo Pharma America, Inc.
-
CLINICAL_TRIALS trial_result · 2017-09-07Clinical Trial Update: Comparison of the Effectiveness of the Outpatient Classical Ketogenic Diet and Modified Atkins Diet on Seizures Frequency, Nutritional Status and Some Biochemical Factors in Children and Adolescents With Intractable Epilepsy [Phase 2, Phase 3]
A Phase 2/Phase 3 trial comparing outpatient classical ketogenic diet versus Modified Atkins Diet for seizure frequency and nutritional/bioc…
-
CLINICAL_TRIALS trial_result · 2017-08-31Clinical Trial Update: PET Study of the Nicotinic System in Epilepsy [NA]
Completed PET imaging study investigating the nicotinic system in epilepsy (NCT03268369).
-
CLINICAL_TRIALS withdrawal · 2017-08-29Clinical Trial Update: Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus [Phase 3]
Phase 3 trial evaluating adjunctive levetiracetam, lacosamide, and ketamine for refractory status epilepticus has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-08-29Clinical Trial Update: Perampanel for Treatment of Adults With Refractory Focal Epilepsy : a Pilot Study. [Phase 4]
A Phase 4 pilot study of perampanel for adults with refractory focal epilepsy has been terminated.
-
FDA approval · 2017-08-15FDA Approved: DILANTIN-125 — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for DILANTIN-125 (phenytoin) submitted by Viatris Specialty LLC.
-
FDA approval · 2017-08-14FDA Approved: LEVETIRACETAM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application to authorize Aurobindo Pharma Limited to manufacture levetiracetam (generic) in the United States.
-
CLINICAL_TRIALS research · 2017-08-09Clinical Trial Update: Depression, Stress and Vulnerability Factors in Drug Resistant Focal Epilepsies [NA]
This clinical trial entry describes a study on depression, stress, and vulnerability factors in drug-resistant focal epilepsies, with the st…
-
CLINICAL_TRIALS trial_result · 2017-08-07Clinical Trial Update: Bioequivalence And Lack Of Food Effects Of 300mg Lamotrigine XR [Phase 1]
Phase 1 study assessing bioequivalence of the 300 mg Lamotrigine extended-release formulation and evaluating absence of a food effect.
-
CLINICAL_TRIALS trial_result · 2017-08-04Clinical Trial Update: AED/Statin Interaction Study [Phase 1]
Phase 1 study evaluating interaction between anti-epileptic drugs and statins has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-02Clinical Trial Update: Evaluation of Long-term Safety, and Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects With Epilepsy [Phase 3]
Phase 3 long-term safety and efficacy results for brivaracetam as adjunctive therapy in epilepsy were reported, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-08-02Clinical Trial Update: Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older [Phase 3]
A Phase 3 clinical trial update evaluating the long-term safety of lacosamide versus carbamazepine controlled-release as initial monotherapy…
-
FDA approval · 2017-07-26FDA Approved: FYCOMPA — Supplemental Application (Eisai Inc.)
FDA approved Eisai Inc.'s supplemental application for FYCOMPA (perampanel), updating the labeling to reflect the approved change.